MS-DRG 821 — Lymphoma and Leukemia with Major O.R. Procedures with CC
MDC 17 · Myeloproliferative Diseases & Neoplasms · Surgical DRG · FY2026
| FY2026 relative weight | 2.2386 |
|---|---|
| Geometric mean LOS | 3.3 days |
| Arithmetic mean LOS | 5.2 days |
| Severity tier | with CC |
| Post-acute transfer policy | No |
| Special payment provision | No |
Severity family — documentation moves the weight 4.87×
The same base condition splits by coded severity (CC/MCC). Weight deltas here are exactly what one documented comorbidity is worth:
| DRG | Title | FY2026 weight | GMLOS |
|---|---|---|---|
| 820 | Lymphoma and Leukemia with Major O.R. Procedures with MCC | 5.8648 | 10.7 |
| 821 | Lymphoma and Leukemia with Major O.R. Procedures with CC | 2.2386 | 3.3 |
| 822 | Lymphoma and Leukemia with Major O.R. Procedures without CC/MCC | 1.2040 | 1.5 |
Figures come from the official FY2026 IPPS tables and are payment inputs, not adjudicated amounts. DRG Calculator prices full claims — hospital-specific operating, capital, IME, DSH, uncompensated care and outlier math — and verifies results against the official pricer.